Vaccination schedule and government pricing intelligence, centralized and always up-to-date.
Vaxivia helps teams track, compare and consume official vaccination schedule and government pricing information across countries through dashboards, structured datasets and API-ready intelligence.
Currently supporting the US and Europe, with expansion to China and other key markets upon request.
Country coverage · Schedule data · Pricing history · Source traceability
Vaccine intelligence is still too fragmented.
Vaccination schedules, recommendation updates and public pricing references are spread across different official sources, countries, formats and update cycles. This makes it difficult for teams to monitor changes, compare markets and maintain reliable internal datasets.
One normalized layer for vaccination schedules and government pricing.
Vaxivia centralizes official-source vaccination schedule and government pricing information, normalizes it into a consistent structure and makes it easier to analyze, compare and integrate.
Monitor
Track official sources and identify relevant updates.
Normalize
Convert country-specific formats into a comparable data structure.
Analyze
Explore schedules, populations, vaccines and pricing history through dashboards.
Integrate
Prepare structured data for exports, APIs and internal systems.
Designed for dashboard insights and structured data access.
Vaxivia is being designed as both a visual intelligence dashboard and a structured data layer for teams that need reliable vaccination schedule and pricing information.
Dashboard preview
Compare countries, vaccines, populations, recommendation logic and source freshness from a centralized dashboard.
Schedule matrix preview
View normalized schedule data by country, disease, vaccine, population, dose number and recommended timing.
| Country | Disease | Vaccine | Population | Doses | Timing |
|---|---|---|---|---|---|
| US | Influenza | IIV4 | Adults 65+ | 1 annual | September–March |
| FR | Pneumococcal | PCV20 | Adults 65+ | Single dose | As recommended |
| DE | COVID-19 | XBB.1.5 | All adults | 1 booster | Autumn 2025 |
| UK | Shingles | RZV | Adults 70+ | 2 doses | 2 months apart |
| ES | HPV | 9vHPV | Ages 12–18 | 2 doses | 6 months apart |
Pricing history preview
Track public and government pricing references over time where available.
API-ready data preview
Prepare vaccination intelligence for integration into internal databases, BI tools and analytics workflows.
{ "country": "FR", "disease": "Pneumococcal disease", "population": "Adults 65+", "vaccine": "PCV20", "recommendation_status": "Recommended", "dose_schedule": "Single dose", "source": "National vaccination calendar", "last_updated": "2026-03-15"}Currently covering the US and Europe. Expanding to China and other key markets.
Vaxivia currently supports vaccination schedule and government pricing intelligence for the United States and Europe, using official-source monitoring and structured normalization.
Coverage is expanding to China and other key markets. Additional countries can be prioritized upon request depending on client needs, source availability and strategic relevance.
Request early access to Vaxivia
Tell us what kind of vaccine intelligence you need. We will review your request and follow up regarding early access, coverage priorities and potential pilot opportunities.
Frequently asked questions
Everything you need to know about Vaxivia.